‘Prophylactic’ use , or Treatment / maintenance / Suppression of a patient’s cancer — prescribed use .
Part of an individual’s treatment regime , & would be part of an individual’s cancer management , in conjunction with hospital oncology monitored or acute treatment :
• at lower dose &
• at a standard dose (eg. for weight / age ) &
• relatively safely .
( as at such a low dose - it is totally different to bisantrene as a regular higher dosed chemotherapeutic agent .)
** Low dose use - not causing side effects in any way , like as if used for chemotherapy treatment .
This is the way that it would be possible . And the reason that it is compelling .
* The Low Dose *
* Consistent between individuals * .
Prophylactically- no not like taking a regular medication though. Really it would be prescribed more on an individual basis .
It has been an excellent discovery for Race Oncology and RAC holders .
*Bisantrene - potential for bisantrene to control the growth of , and to suppress FTO Protein & it’s expression from occurring -
increased FTO Protein being significantly associated with a broad % of , and broad range and type of cancers in some individuals .
( as seen in the table of FTO protein relevant cancers )
I don’t think we quite want to be putting bisantrene into our daily drinking water however .
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC - Charts & Price Action, page-1447
- There are more pages in this discussion • 19,472 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $197.8M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.16 | $45.71K | 38.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2357 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 1200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2357 | 1.165 |
1 | 6000 | 1.160 |
1 | 6000 | 1.155 |
4 | 12286 | 1.150 |
2 | 5887 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 1200 | 1 |
1.215 | 7251 | 1 |
1.220 | 4561 | 1 |
1.235 | 5000 | 1 |
1.250 | 3894 | 1 |
Last trade - 11.30am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.16 |
  |
Change
-0.030 ( 2.11 %) |
|||
Open | High | Low | Volume | ||
$1.19 | $1.19 | $1.16 | 5723 | ||
Last updated 12.05pm 07/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online